The Effect of Synbiotics on the Upper Respiratory Tract Infection

NCT ID: NCT04960878 Phase: NA Status: COMPLETED Enrollment: 58 Completion: 2021-01-05

Conditions

Upper Respiratory Tract Infection, Gut Microbiota, Immune Function

Interventions

Synbiotic, Placebo

Summary

Gut microbiome manipulation to alter the gut-lung axis may potentially protect humans against respiratory infections. However, clinical trials of synbiotics, one of the microbiota-targeted intervention, in this regard is few. Therefore, this study aims to examine the effect of synbiotics on the incidence and severity of upper respiratory tract infection, gut microbiota composition and function, as well as biomarkers of immune function.

Primary Outcome

The incidence of the upper respiratory tract infection

Source

ClinicalTrials.gov